Welcome to Gen-Probe

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods.





GPRO 41.71 -0.29
Nov 20 2009 4:00PM
MORE INFO

Recently acquired FDA-cleared assays from Prodesse

ProFlu+

Pro hMPV+

ProFlu-ST (Emergency Use Authorization)

ProGastro™ Cd

November 16, 2009

Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts

October 30, 2009

Gen-Probe to Webcast Two Upcoming Investor Presentations
Webcasts Webcasts Piper Jaffray Healthcare Conference (Live) 12/02/09 at 2:30 p.m. ET
Gen-Probe Annual Analyst Meeting - New York (Live) 12/03/09 at 9:00 a.m. ET
Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego, CA 92121
USA

Map  |  Terms  |  Privacy  |  Help